David Halstead

David Halstead works with clients in the biotechnology, chemical, and pharmaceutical industries on a wide range of intellectual property issues. He assists clients with obtaining robust and enforceable patents and navigating the existing patent landscape.

Using his experience working with patents and applications in many foreign countries, David also helps clients devise effective global patent strategies designed to satisfy the idiosyncratic requirements of foreign patent offices.

David Halstead works with clients to create and manage their relationships with business partners. He evaluates the intellectual property portfolios of target companies to identify strengths, weaknesses, and opportunities to create value by revising patent strategies and addressing latent issues. Using his understanding of the regulatory environment for pharmaceutical and biotech products, David also advises clients regarding product life-cycle management, including Hatch-Waxman and Orange Book issues.

Before beginning his legal career, David obtained his Ph.D. in Organic Chemistry from Harvard University, where he studied the synthesis of complex organic molecules and completed the total synthesis of discodermolide in the laboratory of Professor David A. Evans.